A Multicentre, Retrospective Study of Clinical Characteristics and Long-term Outcomes of Patients With Brucellosis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-04-27

Study Completion Date

2022-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a multicenter, retrospective clinical study, in patients with brucellosis, to analyze the clinical characteristics, complications, and the impact of different treatment options on long-term prognosis of patients with brucellosis. All hospitalized patients diagnosed with brucellosis between 2016 and 2021 were included from the electronic medical record systems of eight centers, collecting demographics, hospitalization information, clinical information, laboratories, imaging studies, treatment regimens, and disease outcome and other information.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Prospective Evaluation of a New Molecular Tool for Early Diagnosis of Mucormycosis

NCT02845934

Mucormycosis

COMPLETED NA

Real World Study of Classic Infectious Disease

NCT04020536

Brucelloses Epidemic Hemorrhagic Fever Kala-Azar

RECRUITING

A Multi-Site Clinical Evaluation of the ARIES Bordetella Assay in Symptomatic Patients

NCT02862262

Bordetella Infections Bordetella Pertussis Infection Bordetella Parapertussis Infection

COMPLETED NA

Prognosis of Disseminated and Cerebral Toxoplasmosis Hospitalized in Intensive Care in the Era of PCR Diagnosis

NCT06305468

Toxoplasmosis

RECRUITING

Multiple-Center Retrospective Study of Severe and Critical COVID-19 in Shanghai

NCT05422963

COVID-19

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Brucellosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age and gender are not limited;
* Discharged patients diagnosed with brucellosis
* Specific reference to the People's Republic of China's health industry standard "Diagnosis for brucellosis" (WS269-2019) diagnosed as a patient with brucellosis, that is, the patient meets a suspected or clinically diagnosed case and passes the confirmatory test mentioned below at the same time Either to prove:

1. Brucella is isolated from any pathological material culture such as blood, bone marrow, other body fluids and excreta of patients.
2. The test tube agglutination test (SAT) titer is 1:100++ and above, or the patient's course of disease lasts for more than one year and still has clinical symptoms, and the titer is 1:50++ and above.
3. Complement fixation test (CFT) titer is 1:10++ and above.
4. Anti-human immunoglobulin test (Coomb's) titer is 1:400++ and above.
* Volunteer to join this study.

Exclusion Criteria

* History of severe lumbar spine trauma before the diagnosis of brucellosis;
* Have undergone lumbosacral surgery before the diagnosis of brucellosis;
* Scoliosis;
* Currently participating in clinical trials of other drugs or medical devices;
* The researchers think it is not suitable for inclusion.

Eligible Sex

ALL

Accepts Healthy Volunteers

No